Next Pharmaceuticals
Four Venture, Suite 200
Irvine
California
92618
United States
Tel: 949-450-0203
Fax: 949-450-0163
Website: http://www.nextpharmaceuticals.com/
14 articles about Next Pharmaceuticals
-
Next Pharmaceuticals Begins Sale Of Sytrinol® Product
1/10/2014
-
Health Canada Approves Next Pharmaceuticals' Relora®
4/2/2013
-
Next Pharmaceuticals Completes Sale of U.S. Affiliate
11/29/2012
-
Next Pharmaceuticals Announces Vity Awards 2008 Include Next Pharmaceuticals's Relora® and Seditol®
7/14/2008
-
Published Study Reveals Next Pharmaceuticals' Flavoxine(TM) Reduces Multiple Heart Health Risk Factors Including High Cholesterol
6/19/2008
-
Next Pharmaceuticals Announces a New Clinical Study Demonstrating Relora(R) Significantly Relieves Short-Term Anxiety in Healthy Women
5/8/2008
-
Next Pharmaceuticals Discloses Results of Nexrutine(R) Clinical Study
11/29/2007
-
Next Pharmaceuticals: Sleepless in Cincinnati Say Seditol® Promotes Restful Night's Sleep
10/22/2007
-
Next Pharmaceuticals Welcomes Marilyn Barrett, Ph.D.
5/4/2007
-
Next Pharmaceuticals Reveals Nexrutine(R) Prevents Prostate Cancer Progression in Pre-clinical Animal Model
5/2/2007
-
Next Pharmaceuticals Study Shows Citrofen Eases Joint Pain And Lowers Weight
2/13/2007
-
Next Pharmaceuticals Signs Exclusive Supply Agreement With Kelatron For Its New Patented, Chromulin(TM)
1/22/2007
-
Next Pharmaceuticals Launches New Natural Product That Boosts Good Cholesterol And Lowers Bad Cholesterol
12/5/2006
-
Study At University of Texas Finds That Next Pharmaceuticals's Nexrutine(R) Inhibits Prostate Cancer Cell Proliferation
7/27/2006